Benign neoplasm of pancreas

disease
On this page

Also known as benign neoplasm of the pancreasbenign pancreas neoplasmbenign pancreas tumorbenign pancreas tumourbenign pancreatic neoplasmbenign pancreatic tumorbenign pancreatic tumourbenign tumor of pancreasbenign tumor of the pancreasbenign tumour of pancreasbenign tumour of the pancreaspancreas benign neoplasmpancreas neoplasm, benignpancreas tumor, benignpancreatic neoplasm, benignpancreatic tumor, benign

Summary

Benign neoplasm of pancreas (MONDO:0021470) is a cancer and 14 clinical trials. Top therapeutic interventions include alcohol. A subtype of benign digestive system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer
  • Clinical trials: 14

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namebenign neoplasm of pancreas
Mondo IDMONDO:0021470
ICD-10-CMD13.6
ICD-111870352651
NCITC4612
SNOMED CT92264007
UMLSC0347284
MedGen91126
Anatomy (UBERON)UBERON:0001264
Is cancer (heuristic)yes

Also known as: benign neoplasm of the pancreas · benign pancreas neoplasm · benign pancreas tumor · benign pancreas tumour · benign pancreatic neoplasm · benign pancreatic tumor · benign pancreatic tumour · benign tumor of pancreas · benign tumor of the pancreas · benign tumour of pancreas · benign tumour of the pancreas · pancreas benign neoplasm · pancreas neoplasm, benign · pancreas tumor, benign · pancreatic neoplasm, benign · pancreatic tumor, benign

Disease family

This is a subtype of benign digestive system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderbenign digestive system neoplasmbenign neoplasm of pancreas

Related subtypes (9): intestinal benign neoplasm, bile duct papillary neoplasm, pleomorphic adenoma, hepatocellular adenoma, benign neoplasm of stomach, benign neoplasm of esophagus, benign neoplasm of oropharynx, benign neoplasm of gallbladder, hepatobiliary benign neoplasm

Subtypes (2): benign neoplasm of exocrine pancreas, pancreatic lipomatosis duodenal stenosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 14.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified11
PHASE12
PHASE1/PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT05453851PHASE1/PHASE2NOT_YET_RECRUITINGA Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors
NCT01525706PHASE1TERMINATEDEndoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm
NCT03147768PHASE1COMPLETEDLaser Tissue Welding - Distal Pancreatectomy Sealing Study
NCT06167421Not specifiedNOT_YET_RECRUITINGComparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy
NCT07443761Not specifiedACTIVE_NOT_RECRUITINGPatients Undergoing Pancreatic Surgery at the Antwerp University Hospital.
NCT07529626Not specifiedNOT_YET_RECRUITINGAssociation Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
NCT02459041Not specifiedCOMPLETEDClinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph Nodes
NCT03532347Not specifiedCOMPLETEDEndoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study)
NCT03570502Not specifiedUNKNOWNIncidence of POPF in the Resection of the Left Pancreas With RFAT
NCT04716166Not specifiedCOMPLETEDIncentive Spirometry and Upper Abdominal Laparoscopic Surgery
NCT05523154Not specifiedTERMINATEDAnswers in Hours A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures
NCT06024343Not specifiedCOMPLETEDMinimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction
NCT06557408Not specifiedCOMPLETEDPancreatic Fistula After Minimally Invasive Enucleation
NCT07592663Not specifiedCOMPLETEDOncologic Safety and Lymphadenectomy in Parenchyma-Sparing Resection for SPN

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
ALCOHOL41